$4.10
0.081.99%
Last update: Nov 4, 4:00 PM
ImageneBio Inc
IMANASDAQ
The average analyst price target for ImageneBio is $20, 387.8% above the current price. Of 3 analysts, 2 rate it Buy and 1 Sell. Targets range from $2 to $30. The latest change came on Aug 21, 2026, when HC Wainwright & Co. initiated coverage of ImageneBio with a Buy rating and a $28 price target.
Price Target Range — 3 Quarters
Analyst Consensus — 3 Analysts
Rating Trend — Last 9 Months
